cromolyn sodium has been researched along with fluorescein-5-isothiocyanate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durán, WN; Fallek, SR; Hobson, RW; Noel, AA | 1 |
| Akutsu, T; Hosoya, K; Kubo, H; Morimoto, Y; Natsume, H; Sugibayashi, K | 1 |
2 other study(ies) available for cromolyn sodium and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Cromolyn Sodium; Dextrans; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Histamine; Inflammation; Macrophage-1 Antigen; Male; Mast Cells; Mesocricetus; Microcirculation; Microscopy, Video; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor | 1995 |
Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Topics: Adjuvants, Pharmaceutic; Administration, Intranasal; Animals; Anti-Asthmatic Agents; Cromolyn Sodium; Dextrans; Fluorescein-5-isothiocyanate; Fusidic Acid; In Vitro Techniques; Male; Molecular Weight; Nasal Mucosa; Rabbits | 1994 |